Research Tracker›Biomarker Atlas›Marker Pages›Growth Differentiation Factor-15 (GDF-15)

Growth Differentiation Factor-15 (GDF-15): biomarker evidence

Growth Differentiation Factor-15 (GDF-15) appears in 1 entry of the OSMF biomarker atlas, covering Atrial Fibrillation. Across those entries it is mixed in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Atrial Fibrillation

Where Growth Differentiation Factor-15 (GDF-15) is reported

ConditionDirectionCompared againstAssociated symptomsSource
Atrial Fibrillation↕ inconsistenthealthy controls—Rivera-Caravaca et al. 2020

Frequently asked questions

In which conditions is Growth Differentiation Factor-15 (GDF-15) altered?

In the OSMF atlas Growth Differentiation Factor-15 (GDF-15) is reported in Atrial Fibrillation. It is mixed in 1 across 1 entries.

Is there a standard clinical test for Growth Differentiation Factor-15 (GDF-15)?

The atlas entries for Growth Differentiation Factor-15 (GDF-15) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Growth Differentiation Factor-15 (GDF-15) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Growth Differentiation Factor-15 (GDF-15) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/growth-differentiation-factor-15-gdf-15.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.